Recalled Medicines & supplements – Current GIS Alerts 2026
Found 685 recalled products in the Medicines & supplements category. Check batch numbers, shops, and hazard information.
Common hazards in this category
All recalled products
Oxylaxon
Failure of the medicinal products to meet the specified quality requirement manifests as excessively high content of one of the two active substances, oxycodone hydrochloride, which may expose patients to receiving a substandard medicinal product. Potential effects: excessive opioid effect, serious adverse reactions, complications of pain therapy.
Oxylaxon
The failure of the medicinal products to meet the established quality requirement manifests as an excessively high content of one of the two active substances, i.e. oxycodone hydrochloride. Potential effects: risk of overdose, poisoning, and increased opioid adverse effects.
Oxylaxon
A quality defect was identified consisting of an excessively high content of oxycodone hydrochloride in selected product batches, resulting from the use of granulate with incorrect quality parameters. Potential effects: opioid overdose, increased adverse reactions, respiratory depression, serious health complications.
Oxylaxon
In this case, the failure of the medicinal products to meet their specified quality requirement manifests as an excessively high content of one of the two active substances, i.e. oxycodone hydrochloride. Potential effects: opioid overdose, increased adverse reactions, risk to the patient’s health.
Oxylaxon
In this case, the failure of the medicinal products to meet their established quality requirement manifests as an excessively high content of one of the two active substances, i.e. oxycodone hydrochloride. Potential effects: risk of opioid overdose, increased adverse reactions, respiratory complications.
BOSS Energy, Dietary supplement
Presence of undeclared pharmacologically active substances: sildenafil and tadalafil. Unknown origin, purity and dosage. Potential effects: drug interactions, blood pressure drop, arrhythmias, serious reactions in people taking PDE5 inhibitors or nitrates.
Linezolid Polpharma
Incorrect release of the active substance from the medicinal product, to an extent that may affect its therapeutic properties, constitutes a real risk to patients' health due to the potential lack of efficacy. Potential effects: ineffective treatment of infections, risk of disease progression or complications.
Benodil
The quality defect consists in labelling Benodil 0.25 mg/ml ampoules with Budixon Neb 0.5 mg/ml labels, which may mislead regarding the dose and use of the medicine. Potential effects: incorrect dosing, lack of therapeutic efficacy, or risk of complications in patients requiring an accurate corticosteroid dose.
Benodil
Failure to meet quality requirements consists in ampoules being labeled as a different medicinal product with a higher strength, which may cause dosing mix‑ups and medication errors. Potential effects: lack of treatment efficacy or complications related to incorrect dosing.
Linezolid Polpharma
Stability testing showed non-compliance in active substance release after 30 minutes, which may affect the product’s effectiveness and poses a real risk to patient health due to potential lack of efficacy. Potential effects: treatment failure, risk of infection progression.
Benodil
there is a justified suspicion that the unit packs of the medicinal product contain a product with a significantly higher dose of active substance than indicated on the outer labelling, creating a real risk that patients will take several times the intended dose. Potential effects: overdose of inhaled medicine, increased corticosteroid side effects, complications in sensitive patients.
Temozolomide Sun
The active substance content is reduced below the lower acceptable limit specified in the product specification, which affects the medicinal product’s effectiveness. Potential effects: lack of treatment efficacy.
Temozolomide Sun
Stability testing showed that the product does not meet quality specification requirements for active substance content; the content is reduced below the lower acceptance limit, which affects the product’s effectiveness. Potential effects: reduced treatment efficacy, possible lack of therapeutic effect.
BOSS Energy Extra, Food supplement
Detected sildenafil, a medicinal substance prohibited in dietary supplements; consumption may pose health risks. Potential effects: cardiovascular disturbances, drug interactions (e.g. nitrates), complications in people with heart conditions.
Mebelin
Testing by the National Medicines Institute showed that the product does not meet quality requirements: release of mebeverine hydrochloride after 2, 8 and 12 hours was below the lower acceptance limit, which affects the effectiveness of the medicine. Potential effects: reduced effectiveness in treating intestinal complaints and possible worsening of disease symptoms.
Mebelin
Tests by the National Medicines Institute showed that the product does not meet the quality specification for mebeverine hydrochloride release – release after 2, 8 and 12 hours was below the lower acceptance limit, affecting the product’s effectiveness. Potential effects: lack or reduction of therapeutic efficacy, possible worsening of disease symptoms.
White Horse – dietary supplement
Detected sildenafil — an undeclared pharmacologically active substance in the product. Potential effects: drug interactions, cardiovascular disturbances, poisoning.
Ozempic
Keeping a falsified medicinal product on the market poses a direct and real threat to patients’ health and potentially life; there is no confirmation of the actual composition of the falsified product or its impact on pharmacological, immunological or metabolic action. Potential effects: poisoning, lack of treatment efficacy, severe complications.
Ozempic
Leaving a falsified medicinal product on the market poses a direct and real threat to patients’ health and potentially life; there is no confirmation of its actual composition or its effect on the medicine’s action. Potential effects: poisoning, lack of treatment efficacy, severe complications, life-threatening events.
Symibace
Stability studies showed a significant exceedance of the specification limit for impurity B, which poses a real and direct risk to patients’ health or life until the cause of the non-compliance is clarified. Potential effects: poisoning, serious adverse reactions, life-threatening events.
What to do if you bought a recalled product?
If you have purchased any of the products listed above, stop using or consuming them immediately. You can return the product to the store where you bought it for a full refund. Keep the receipt if possible, but most stores will accept returns even without one.